InvestorsHub Logo
Followers 3
Posts 398
Boards Moderated 0
Alias Born 01/08/2015

Re: None

Monday, 02/23/2015 1:25:05 PM

Monday, February 23, 2015 1:25:05 PM

Post# of 43722
I finally had some free time today to listen, read, and watch the interviews that took place the past few days. Here is a stock that the CEO said that he has been adding positions (10%) at higher prices, Phase 3 clinical trial and reporting good progress, arbitration coming to and end in a few months, Navy anal wart P1 study, etc. He also stated that he believes that the current stock price for CVM is too low comparing to other P3 biotech companies and thinks that it should have a market cap of $1B minimum ($10/sh) for now. He seems very confident that things will pan out.

Yet, it is still hovering at $.90/sh so we will have to wait and see until minimum end of this year to see where all of this will go. Somebody is not trusting the end results or the management team until it is proven or the drug doesn't work, unlikely. I will wait this out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVM News